Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.57 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.52 |
| ▸ | TSHR | P16473 | 3/20 | 0.52 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.52 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.50 |
| ▸ | POLB | P06746 | 3/20 | 0.47 |
| ▸ | GAA | P10253 | 1/20 | 0.47 |
| ▸ | HTT | P42858 | 2/20 | 0.47 |
| ▸ | CA12 | O43570 | 1/20 | 0.46 |
| ▸ | CA1 | P00915 | 1/20 | 0.46 |
| ▸ | CA9 | Q16790 | 1/20 | 0.46 |
| ▸ | RAB9A | P51151 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.46 |
| ▸ | GLA | P06280 | 1/20 | 0.46 |
| ▸ | LMNA | P02545 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31677054 | 1.00 | L3MBTL1 (0.57) | L3MBTL1SMN1; SMN2TSHRALOX15HSD17B10 | |
| SCHEMBL20547280 | 0.98 | L3MBTL1 (0.59) | L3MBTL1SMN1; SMN2TSHRALOX15HSD17B10 | |
| SCHEMBL78389 | 0.98 | L3MBTL1 (0.59) | L3MBTL1SMN1; SMN2TSHRALOX15HSD17B10 | |
| SCHEMBL18011765 | 0.98 | L3MBTL1 (0.59) | L3MBTL1SMN1; SMN2TSHRALOX15HSD17B10 | |
| Hydrochloric Acid SCHEMBL8118571 | 0.95 | L3MBTL1 (0.57) | L3MBTL1SMN1; SMN2TSHRALOX15HSD17B10 | |
| SCHEMBL773501 | 0.90 | L3MBTL1 (0.52) | L3MBTL1SMN1; SMN2TSHRALOX15HSD17B10 | |
| SCHEMBL11742016 | 0.90 | L3MBTL1 (0.52) | L3MBTL1SMN1; SMN2TSHRALOX15HSD17B10 | |
| Propionic Acid SCHEMBL23466968 | 0.86 | ALDH1A1 (0.49) | L3MBTL1SMN1; SMN2TSHRALOX15HSD17B10 | |
| SCHEMBL22196916 | 0.85 | ALOX15 (0.72) | L3MBTL1SMN1; SMN2TSHRALOX15HSD17B10 | |
| SCHEMBL18633170 | 0.84 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090104124-A1 | Paramagnetic Complexes with Pendant Crown Compounds Showing Improved Targeting- Specificity as MRI Contrast Agents | UNIVERSITY HONG KONG, THE (CN) | 2009-04-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090104124-A1 | Paramagnetic Complexes with Pendant Crown Compounds Showing Improved Targeting- Specificity as MRI Contrast Agents | ABCB11, ATP6V1B1, SLC5A7 | L3MBTL1 656/4885SMN1; SMN2 1076/4885TSHR 2067/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.